✉news HealthFitness first seen 5 d ago, last 5 d ago, peak #16

Quantum BioPharma's Unbuzzd Trial Results Examined by Men's Fitness

Original: Quantum BioPharma (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Results

Quantum BioPharma, a NASDAQ-listed company trading under QNTM, has been featured in a Men's Fitness article examining clinical trial results for Unbuzzd, its product aimed at reducing alcohol's effects. The coverage highlights growing mainstream attention on the company's research, with investors and health-focused readers closely watching how the trial data may support the product's claims and commercial prospects.

Why now: Investors and wellness audiences are tracking new clinical trial coverage of a NASDAQ-listed company's alcohol-mitigation product.

Quantum BioPharmaUnbuzzdMen's FitnessNASDAQ

Open on news →

Evidence

• Quantum BioPharma (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Results · USA Today

API: https://socialmediatrends-api.osmike.com/v1/trends/3018018